Intratympanic dexamethasone to prevent cisplatin ototoxicity: A guinea pig model

Otolaryngology - Head and Neck Surgery

Volumn 145, Issue 3, 2011, Pages 452-457

  Murphy, Denise ^a   Daniel, Sam J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Cisplatin; Dexamethasone; Evoked potentials; Intratympanic; Ototoxicity

Indexed keywords

CISPLATIN; DEXAMETHASONE; FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY RESPONSE; AUDITORY THRESHOLD; CONTROLLED STUDY; DRUG EFFECT; EAR PROTECTION; EXPERIMENTAL GUINEA PIG; FEMALE; INNER EAR DISEASE; NONHUMAN; OTOTOXICITY; PERCEPTION DEAFNESS; PROSPECTIVE STUDY; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG ADMINISTRATION; EARDRUM; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; INTRALESIONAL DRUG ADMINISTRATION; RANDOMIZATION; TREATMENT OUTCOME;

ANIMALS; CISPLATIN; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GUINEA PIGS; HEARING LOSS, SENSORINEURAL; INJECTIONS, INTRALESIONAL; RANDOM ALLOCATION; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 80055080060     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811406673     Document Type: Article

References (29)

1. Bokemeyer C, Berger CC, Hartmann JT, et al. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer. 1998;77(8):1355-1362. (Pubitemid 28140629)
2. Allen GC, Tiu C, Koike K, et al. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy. Otolaryngol Head Neck Surg. 1998;118(5):584-588. (Pubitemid 28222198)
3. Komune S, Asakuma S, Snow JB Jr. Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol Head Neck Surg. 1981;89(2):275-282. (Pubitemid 11090690)
4. Nakai Y, Konishi K, Chang KC, et al. Ototoxicity of the anticancer drug cisplatin. An experimental study. Acta Otolaryngol. 1982;93(3-4):227-232. (Pubitemid 12173676)
5. van Ruijven MW, de Groot JC, Klis SF, Smoorenburg GF. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res. 2005;205(1-2):241-248. (Pubitemid 40813286)
6. Rybak LP, Whitworth CA, Mukherjea D, et al. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res. 2007;226(1-2):157-167. (Pubitemid 46428033)
7. Dehne N, Lautermann J, Petrat F, et al. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol. 2001;174(1):27-34. (Pubitemid 32635003)
8. So H, Kim H, Lee JH, et al. Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol. 2007;8(3):338-355. (Pubitemid 47222431)
9. Banfi B, Malgrange B, Knisz J, et al. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem. 2004;279(44):46065-46072. (Pubitemid 39491600)
10. Kolls J, Xie J, LeBlanc R, et al. Rapid induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin and its suppression by prednisolone. Proc Soc Exp Biol Med. 1994;205(3):220-229.
11. Nagura M, Iwasaki S, Wu R, et al. Effects of corticosteroid, contrast medium and ATP on focal microcirculatory disorders of the cochlea. Eur J Pharmacol. 1999;366(1):47-53. (Pubitemid 29076720)
12. Haake SM, Dinh CT, Chen S, et al. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hear Res. 2009;255(1-2):22-32.
13. Himeno C, Komeda M, Izumikawa M, et al. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res. 2002;167(1-2):61-70. (Pubitemid 34756851)
14. Park SK, Choi D, Russell P, et al. Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope. 2004;114(4):768-771. (Pubitemid 38548795)
15. Zuur CL, Simis YJ, Lansdaal PE, et al. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer. J Clin Oncol. 2007;25(24):3759-3765. (Pubitemid 47372618)
16. Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23(34):8588-8596. (Pubitemid 46211500)
17. Gurney JG, Tersak JM, Ness KK, et al. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group. Pediatrics. 2007;120(5):e1229-e1236. (Pubitemid 350085519)
18. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005;10(19):1313-1321. (Pubitemid 41416704)
19. Harned T, Kalous O, Neuwelt A, et al. Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity. Clin Cancer Res. 2008;14(2):533-540. (Pubitemid 351226123)
20. More S, Akil O, Ianculescu A, et al. Role of copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci. 2010;30(28):9500-9509.
21. Daldal A, Odabasi O, Serbetcioglu B. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg. 2007;137(5):747-752. (Pubitemid 47632918)
22. Hill GW, Morest DK, Parham K. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections. Otol Neurotol. 2008;29(7):1005-1011.
23. Greenwood DD. A cochlear frequency-position function for several species - 29 years later. J Acoust Soc Am. 1990;87(6):2592-2605. (Pubitemid 20289735)
24. Sha SH, Taylor R, Forge A, et al. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 2001;155(1-2):1-8. (Pubitemid 32401586)
25. Jinn TH, Kim PD, Russell PT, et al. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells. Laryngoscope. 2001;111(12):2105-2108. (Pubitemid 33117205)
26. Choe WT, Chinosornvatana N, Chang KW. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol. 2004;25(6):910-915. (Pubitemid 39491671)
27. MacArthur C, Hefeneider S, Kempton J, et al. Evaluation of the mouse model for acute otitis media. Hear Res. 2006;219(1-2):12-23. (Pubitemid 44189125)
28. Hargunani CA, Kempton JB, DeGagne JM, et al. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol. 2006;27(4):564-569.
29. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109(7 pt 2):1-17. (Pubitemid 29315126)